Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


23.09.2019

1 Angiology
3 Ann Thorac Surg
2 Arterioscler Thromb Vasc Biol
1 Circ Cardiovasc Imaging
1 Circ J
1 Circulation
1 Eur Heart J
9 J Am Coll Cardiol
1 J Clin Endocrinol Metab
3 JAMA
1 N Engl J Med
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Angiology

  1. KUPO P, Szakacs Z, Solymar M, Habon T, et al
    Direct Anticoagulants and Risk of Myocardial Infarction, a Multiple Treatment Network Meta-Analysis.
    Angiology. 2019 Sep 18:3319719874255. doi: 10.1177/0003319719874255.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. NAWATA K, D'Agostino RS, Habib RH, Kumamaru H, et al
    First Database Comparison Between the United States and Japan; Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2019 Sep 17. pii: S0003-4975(19)31399.
    PubMed     Text format     Abstract available

  3. PARK SJ, Kim HJ, Kim JB, Jung SH, et al
    Sequential versus Individual Saphenous Vein Grafting during Coronary Arterial Bypass Surgery.
    Ann Thorac Surg. 2019 Sep 17. pii: S0003-4975(19)31398.
    PubMed     Text format     Abstract available

  4. BIANCO V, Kilic A, Gleason TG, Aranda-Michel E, et al
    Midterm outcomes for isolated coronary artery bypass grafting in octogenarians.
    Ann Thorac Surg. 2019 Sep 17. pii: S0003-4975(19)31401.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  5. BEECH DJ, Kalli AC
    Force Sensing by Piezo Channels in Cardiovascular Health and Disease.
    Arterioscler Thromb Vasc Biol. 2019 Sep 19:ATVBAHA119313348.
    PubMed     Text format     Abstract available

  6. MUELLER PA, Yang L, Ubele M, Mao G, et al
    Coronary Artery Disease Risk-Associated Plpp3 Gene and Its Product Lipid Phosphate Phosphatase 3 Regulate Experimental Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2019 Sep 19:ATVBAHA119313056.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  7. RAMCHAND J, Jaber W, Hachamovitch R
    Identifying Likelihood of Obstructive Coronary Disease in Patients With a Calcium Score of Zero: Separating the Wheat From the Chaff.
    Circ Cardiovasc Imaging. 2019;12:e009649.
    PubMed     Text format    


    Circ J

  8. ADACHI M, Watanabe M, Kurata Y, Inoue Y, et al
    beta-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.
    Circ J. 2019 Sep 13. doi: 10.1253/circj.CJ-19-0261.
    PubMed     Text format     Abstract available


    Circulation

  9. MARSTON NA, Giugliano RP, Im K, Silverman MG, et al
    Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
    Circulation. 2019 Sep 18. doi: 10.1161/CIRCULATIONAHA.119.041998.
    PubMed     Text format     Abstract available


    Eur Heart J

  10. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
    Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
    Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  11. LAU ES, Paniagua SM, Guseh JS, Bhambhani V, et al
    Sex Differences in Circulating Biomarkers of Cardiovascular Disease.
    J Am Coll Cardiol. 2019;74:1543-1553.
    PubMed     Text format     Abstract available

  12. MOTIWALA SR
    From Proteomics to Therapeutics: Sex Differences in Cardiovascular Disease Risk Do Matter.
    J Am Coll Cardiol. 2019;74:1554-1556.
    PubMed     Text format    

  13. AHMADI A, Argulian E, Leipsic J, Newby DE, et al
    From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:1608-1617.
    PubMed     Text format     Abstract available

  14. SZUMMER K, Jernberg T, Wallentin L
    From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:1618-1636.
    PubMed     Text format     Abstract available

  15. MEHTA A, Dhindsa DS, Sandesara PB
    Enhancing Preventive Cardiovascular Medicine Training During General Cardiology Fellowship.
    J Am Coll Cardiol. 2019;74:1637-1641.
    PubMed     Text format    

  16. BLUMENTHAL RS
    RESPONSE: All Cardiovascular Health Professionals Need to Know the ABCDEs of Primary and Secondary Prevention.
    J Am Coll Cardiol. 2019;74:1640-1641.
    PubMed     Text format    

  17. KARAYIANNIDES S, Norhammar A, Frobert O, James SK, et al
    Prognosis in Patients With Diabetes Mellitus and STEMI Undergoing Primary PCI.
    J Am Coll Cardiol. 2018;72:1427-1428.
    PubMed     Text format    

  18. JOLLY SS, Cairns JA, Lavi S, Cantor WJ, et al
    Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial.
    J Am Coll Cardiol. 2018;72:1589-1596.
    PubMed     Text format     Abstract available

  19. CORBALAN R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, et al
    Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2018;72:1466-1475.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  20. AL-SOFIANI ME, Yanek LR, Faraday N, Kral BG, et al
    Diabetes and Platelet Response to Low-dose Aspirin.
    J Clin Endocrinol Metab. 2018 Sep 27. pii: 5107300. doi: 10.1210/jc.2018-01254.
    PubMed     Text format     Abstract available


    JAMA

  21. WEXLER DJ
    Sulfonylureas and Cardiovascular Safety: The Final Verdict?
    JAMA. 2019 Sep 19. pii: 2751396. doi: 10.1001/jama.2019.14533.
    PubMed     Text format    

  22. ROUMIE CL, Chipman J, Min JY, Hackstadt AJ, et al
    Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function.
    JAMA. 2019 Sep 19:1-11. doi: 10.1001/jama.2019.13206.
    PubMed     Text format     Abstract available

  23. ROSENSTOCK J, Kahn SE, Johansen OE, Zinman B, et al
    Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
    JAMA. 2019 Sep 19. pii: 2751398. doi: 10.1001/jama.2019.13772.
    PubMed     Text format     Abstract available


    N Engl J Med

  24. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    PubMed     Text format     Abstract available


    PLoS One

  25. KWONG RY, Heydari B, Ge Y, Abdullah S, et al
    Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled tria
    PLoS One. 2019;14:e0222061.
    PubMed     Text format     Abstract available

  26. VALLABHAJOSYULA S, Dunlay SM, Barsness GW, Vallabhajosyula S, et al
    Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock.
    PLoS One. 2019;14:e0222894.
    PubMed     Text format     Abstract available

  27. IJICHI T, Nakazawa G, Torii S, Nagamatsu H, et al
    Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery.
    PLoS One. 2019;14:e0209841.
    PubMed     Text format     Abstract available

  28. GARCIA D, Harbaoui B, van de Hoef TP, Meuwissen M, et al
    Relationship between FFR, CFR and coronary microvascular resistance - Practical implications for FFR-guided percutaneous coronary intervention.
    PLoS One. 2019;14:e0208612.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: